Norman Paul, a Director, disposed of 250,000 Common Shares on an indirect ownership basis for registered holder The Norman Paul 2013 Family Trust at a price of $9.540 on December 29th, 2017. This represents a $2,385,000 divestment of the company's shares and an account share holdings change of -4.2%.
CannTrust Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
CannTrust Holdings Inc is a Canada-based company, which produces pharmaceutical-grade medical cannabis for patients. The Company is a federally regulated licensed producer of medical cannabis products. The Company operates a hydroponic facility and an onsite laboratory for testing and research on the medical use of cannabis. The Company's exclusive pharmaceutical partner is Apotex. CannTrust Holdings Inc's products are divided into the following: Products Type, such as oil, dried cannabis, accessories and patient ready; Strain Type, such as hybrid, sativa dominant and indica dominant, as well as Strength, such as strong, mild and moderate. The Company's products are sold online through its Website.
No Comments